Követés
Calvin Ke
Calvin Ke
Epidemiologic and Applied Research Lab in Young‑Onset Diabetes​, University of Toronto
E-mail megerősítve itt: utoronto.ca - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas
R Williams, S Karuranga, B Malanda, P Saeedi, A Basit, S Besançon, ...
Diabetes research and clinical practice 162, 108072, 2020
9562020
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults
NH Phelps, RK Singleton, B Zhou, RA Heap, A Mishra, JE Bennett, ...
The Lancet 403 (10431), 1027-1050, 2024
6252024
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations
C Ke, KMV Narayan, JCN Chan, P Jha, BR Shah
Nature Reviews Endocrinology 18 (7), 413-432, 2022
1672022
Divergent trends in ischaemic heart disease and stroke mortality in India from 2000 to 2015: a nationally representative mortality study
C Ke, R Gupta, D Xavier, D Prabhakaran, P Mathur, YV Kalkonde, ...
The Lancet Global Health 6 (8), e914-e923, 2018
1032018
Excess burden of mental illness and hospitalization in young-onset type 2 diabetes
C Ke, BR Shah, TA Stukel, JCN Chan, A Luk
Annals of internal medicine 171 (1), 78-79, 2019
832019
Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: a retrospective cohort study
AOY Luk, C Ke, ESH Lau, H Wu, W Goggins, RCW Ma, E Chow, ...
PLoS Medicine 17 (2), e1003052, 2020
692020
Current insights and emerging trends in early-onset type 2 diabetes
S Misra, C Ke, S Srinivasan, A Goyal, MJ Nyriyenda, JC Florez, K Khunti, ...
The Lancet Diabetes & Endocrinology 11 (10), 768-782, 2023
662023
Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: a population-based observational study
C Ke, TA Stukel, BR Shah, E Lau, RC Ma, WY So, AP Kong, E Chow, ...
PLoS Medicine 17 (9), e1003316, 2020
492020
Diminishing benefits of urban living for children and adolescents’ growth and development
Nature 615 (7954), 874-883, 2023
432023
IDF Atlas 9th
R Williams, S Colagiuri, J Chan, E Gregg, C Ke, LL Lim, X Yang
International Diabetes Federation, 2019
41*2019
Association of hypertension and diabetes with ischemic heart disease and stroke mortality in India: the million death study
C Ke, R Gupta, BR Shah, TA Stukel, D Xavier, P Jha
Global heart 16 (1), 2021
302021
Cardiovascular outcomes trials in type 2 diabetes: time to include young adults
C Ke, BR Shah, AO Luk, E Di Ruggiero, JCN Chan
Diabetes Obes Metab 22 (1), 3-5, 2020
302020
Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
Nature medicine 29 (11), 2885-2901, 2023
292023
Beyond pros and cons–developing a patient decision aid to cultivate dialog to build relationships: insights from a qualitative study and decision aid development
CH Yu, C Ke, A Jovicic, S Hall, SE Straus, ...
BMC medical informatics and decision making 19, 1-12, 2019
292019
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
B Zhou, AW Rayner, EW Gregg, KE Sheffer, RM Carrillo-Larco, ...
The Lancet 404 (10467), 2077-2093, 2024
272024
Diabetes in the young: a population‐based study of South Asian, Chinese and White people
C Ke, P Sohal, H Qian, H Quan, NA Khan
Diabetic Medicine 32 (4), 487-496, 2015
262015
Trends in the association between diabetes and cardiovascular events, 1994-2019
C Ke, LL Lipscombe, A Weisman, L Zhou, PC Austin, BR Shah, GL Booth
JAMA 328 (18), 1866-1869, 2022
242022
Development and validation of algorithms to classify type 1 and 2 diabetes according to age at diagnosis using electronic health records
C Ke, TA Stukel, A Luk, BR Shah, P Jha, E Lau, RCW Ma, WY So, ...
BMC medical research methodology 20, 1-15, 2020
162020
Mortality and cardiovascular risk of sulfonylureas in South Asian, Chinese and other Canadians with diabetes
C Ke, S Morgan, K Smolina, D Gasevic, H Qian, N Khan
Canadian Journal of Diabetes 41 (2), 150-155, 2017
162017
Process evaluation of the diabetes Canada guidelines dissemination strategy using the reach effectiveness adoption implementation maintenance (RE-AIM) framework
HY Catherine, CG Casey, C Ke, G Lebovic, SE Straus
Canadian Journal of Diabetes 43 (4), 263-270. e9, 2019
112019
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20